Inotiv Inc (NOTV) Directors and Executive Officers

Officers & Directors

Michael Harrington
Director

R. Matthew Neff
Chairman of the Board of Directors

Robert W. Leasure, Jr.
President, Chief Executive Officer, and Director

Nigel Brown
Director

John E. Sagartz
Director

Beth A. Taylor
Chief Financial Officer and Senior Vice President of Finance

David Landman
Director

Brennan Freeman
Vice President of Finance and Corporate Controller

Terry Coelho
Director ,

Inotiv Inc currently has 2046 employees.

News about Inotiv Inc Key Personnel

Inotiv, Inc. Faces Setbacks as Shares Plummet and Net Losses Mount

Inotiv, Inc. (Nasdaq: NOTV), a renowned contract research organization focused on nonclinical and analytical drug discovery and development services, has recently experienced a series of challenges. The company s shares have plummeted by a staggering 64% over the past month, reflecting investor concerns. Furthermore, Inotiv s financial reports indicate a cumulative net loss of $71 million during the 12 months ending in the second quarter of 2024, resulting in a worrying negative return on investment (ROI) of -11.4%.
These developments highlight the difficulties that Inotiv currently faces in the highly competitive healthcare sector. As the company struggles to turn a profit, 179 other companies...

Inotiv, Inc. Partners with Vanguard to Insourcing Transportation Operations Amidst Cumulative Net Losses: Assessing Strategies for Growth

Inotiv, Inc. Announces Plan to Insourcing North American Transportation Operations Despite Cumulative Net Losses
Inotiv, Inc., a prominent contract research organization specializing in nonclinical and analytical drug discovery and development services, as well as research models and related products and services, has recently revealed its intention to partner with Vanguard Supply Chain Solutions LLC to bring its North American transportation operations in-house. This decision comes in light of the company s recorded cumulative net loss of $-338 million during the 12-month period ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -45.1%.
The partnership with V...